2.36
0.01 (0.43%)
Previous Close | 2.35 |
Open | 2.35 |
Volume | 111,969 |
Avg. Volume (3M) | 879,181 |
Market Cap | 117,358,312 |
Price / Sales | 0.870 |
Price / Book | 0.550 |
52 Weeks Range | |
Earnings Date | 7 Jun 2023 - 12 Jun 2023 |
TTM Dividend Yield | 26.21% |
Profit Margin | -73.25% |
Operating Margin (TTM) | -21.84% |
Diluted EPS (TTM) | -0.140 |
Quarterly Revenue Growth (YOY) | -14.30% |
Total Debt/Equity (MRQ) | 6.73% |
Current Ratio (MRQ) | 3.04 |
Operating Cash Flow (TTM) | -14.96 M |
Levered Free Cash Flow (TTM) | -18.95 M |
Return on Assets (TTM) | -7.46% |
Return on Equity (TTM) | -12.94% |
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (US) | Mixed | Mixed |
Diagnostics & Research (Global) | Mixed | Mixed | |
Stock | Enzo Biochem, Inc. | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -5.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 0.0 |
Average | -0.63 |
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
Investment Style | Small Value |
% Held by Insiders | 21.68% |
% Held by Institutions | 34.79% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |